Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
lung | 100% | 866.47 | 578 / 578 | 100% | 31.47 | 1155 / 1155 |
ovary | 100% | 878.40 | 180 / 180 | 100% | 33.63 | 430 / 430 |
esophagus | 100% | 805.09 | 1444 / 1445 | 100% | 35.31 | 183 / 183 |
uterus | 100% | 765.03 | 170 / 170 | 100% | 40.04 | 458 / 459 |
intestine | 100% | 743.01 | 965 / 966 | 100% | 44.74 | 526 / 527 |
breast | 100% | 838.37 | 459 / 459 | 99% | 23.57 | 1112 / 1118 |
bladder | 100% | 893.62 | 21 / 21 | 99% | 35.98 | 501 / 504 |
prostate | 100% | 621.61 | 244 / 245 | 99% | 19.36 | 499 / 502 |
stomach | 99% | 480.19 | 355 / 359 | 100% | 41.73 | 286 / 286 |
skin | 100% | 875.93 | 1807 / 1809 | 99% | 40.79 | 467 / 472 |
thymus | 100% | 541.78 | 652 / 653 | 98% | 16.90 | 590 / 605 |
brain | 98% | 373.11 | 2602 / 2642 | 99% | 18.96 | 697 / 705 |
adrenal gland | 100% | 534.79 | 258 / 258 | 97% | 16.00 | 222 / 230 |
pancreas | 96% | 292.60 | 315 / 328 | 99% | 22.88 | 177 / 178 |
liver | 98% | 417.11 | 222 / 226 | 94% | 14.58 | 380 / 406 |
kidney | 98% | 384.57 | 87 / 89 | 91% | 13.48 | 818 / 901 |
adipose | 100% | 969.12 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 717.50 | 1335 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 58.49 | 29 / 29 |
spleen | 100% | 1259.15 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 34.84 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 19.56 | 1 / 1 |
muscle | 100% | 867.73 | 802 / 803 | 0% | 0 | 0 / 0 |
peripheral blood | 98% | 1200.12 | 915 / 929 | 0% | 0 | 0 / 0 |
heart | 98% | 668.25 | 848 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 94% | 24.10 | 75 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0048821 | Biological process | erythrocyte development |
GO_0050766 | Biological process | positive regulation of phagocytosis |
GO_0045087 | Biological process | innate immune response |
GO_0000122 | Biological process | negative regulation of transcription by RNA polymerase II |
GO_0045824 | Biological process | negative regulation of innate immune response |
GO_0045943 | Biological process | positive regulation of transcription by RNA polymerase I |
GO_0006364 | Biological process | rRNA processing |
GO_0005730 | Cellular component | nucleolus |
GO_0001750 | Cellular component | photoreceptor outer segment |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005737 | Cellular component | cytoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0003677 | Molecular function | DNA binding |
GO_0140297 | Molecular function | DNA-binding transcription factor binding |
GO_0140416 | Molecular function | transcription regulator inhibitor activity |
GO_0042802 | Molecular function | identical protein binding |
GO_0046872 | Molecular function | metal ion binding |
GO_0003723 | Molecular function | RNA binding |
GO_0005515 | Molecular function | protein binding |
Gene name | LYAR |
Protein name | Ly1 antibody reactive Cell growth-regulating nucleolar protein |
Synonyms | PNAS-5 |
Description | FUNCTION: Plays a role in the maintenance of the appropriate processing of 47S/45S pre-rRNA to 32S/30S pre-rRNAs and their subsequent processing to produce 18S and 28S rRNAs . Also acts at the level of transcription regulation. Along with PRMT5, binds the gamma-globin (HBG1/HBG2) promoter and represses its expression . In neuroblastoma cells, may also repress the expression of oxidative stress genes, including CHAC1, HMOX1, SLC7A11, ULBP1 and SNORD41 that encodes a small nucleolar RNA . Preferentially binds to a DNA motif containing 5'-GGTTAT-3' . Negatively regulates the antiviral innate immune response by targeting IRF3 and impairing its DNA-binding activity . In addition, inhibits NF-kappa-B-mediated expression of pro-inflammatory cytokines . Stimulates phagocytosis of photoreceptor outer segments by retinal pigment epithelial cells (By similarity). Prevents nucleolin/NCL self-cleavage, maintaining a normal steady-state level of NCL protein in undifferentiated embryonic stem cells (ESCs), which in turn is essential for ESC self-renewal (By similarity). . |
Accessions | ENST00000452476.5 ENST00000513174.1 D6RDJ1 ENST00000343470.9 Q9NX58 |